A.P. Pharma, Inc. (NASDAQOTCBB:APPA)

CAPS Rating: 1 out of 5

A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.

Recs

0
Player Avatar pchop123 (76.64) Submitted: 11/27/2012 7:03:03 PM : Underperform Start Price: $0.52 APPA Score: +5.96

too much dilution for me

Featured Broker Partners


Advertisement